Relation of EPA and DHA content in cellular membranes of red blood cells to clinical outcome in patients hospitalized with chest pain.
The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction.
Thromb Res 2007;119(4):415-21. Epub 2006 mai 2
Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction.
Eur J Clin Nutr 2007 Mar. Epub 2007 mar 7
Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI).
J Thromb Thrombolysis 2007 Oct;24(2):131-5. Epub 2007 mai 11
Change to a primary PCI program increases number of patients offered reperfusion therapy and significantly reduces mortality: a real life experience evaluating the initiation of a primary PCI service at a single center without on site heart surgery in Western Norway.
Int J Cardiol 2008 Jul;127(2):208-13. Epub 2007 sep 4
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
J Intern Med 2007 Aug;262(2):244-53.
Late complications following the deployment of drug eluting stents.
Int J Cardiol 2006 May;109(3):398-401. Epub 2005 aug 18
Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Thromb Haemost 2006 Feb;95(2):329-36.
Acute occlusion of the left subclavian artery causing a non-ST-elevation myocardial infarction with subacute lung edema due to a coronary subclavian steal syndrome--a case report.
Int J Cardiol 2006 Mar;108(1):139-41.
Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients.
Am Heart J 2006 Nov;152(5):888-95.
Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase.
J Thromb Thrombolysis 2006 Dec;22(3):199-203.
Cardiac omega-3 content and risk of future cardiovascular events following an acute coronary syndrome.
European Heart Journal 2007;Vol.28 (Abstract Supplement):265: P3561, ESC Congress, Vienna 1-5 Sept 2007.
WENBIT - Western Norway B-vitamin intervention trial.
Hotline III, Session number 3220, presentation by Marta Ebbing on Sept. 4, ESC Congress, Vienna 1-5 Sept 2007.
The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction.
European Heart Journal 2007;Vol.28 (Abstract Supplement):265: Oral presentation, abstract 1699. , ESC Congress 2007, Vienna1-5 Sept 2007.
Activated Factor XII Type A predicts cardiovascular outcome in patients admitted with chest pain.
European Heart Journal 2007;Vol.28 (Abstract Supplement):113: Poster presentation, ESC Congress 2007, Vienna 1-5 Sept. 2007.
Activated factor XII type A independently predicts 12 month mortality in chest pain patients.
Poster presentation at International Congress on Thrombosis and Haemostasis, Geneva, July 6-12, 2007. J Thromb Haemost 2007; Abstract ISTH 07A1_P-W-009.
NT-proBNP, and not TF, FM; PAPPA-A or CD40 Ligand, predicts recurrent troponin-T positive cardiac events following an acute myoc
Poster presentation at International Congress on Thrombosis and Haemostasis, Geneva, July 6-12, 2007. J Thromb Haemost 2007; Abstract ISTH 07A1_P-M-585.
WENBIT – Western Norway B-vitamin Intervention. 6th Conference on Homocysteine Metabolism.
World Congress on Hyperhomocysteinemia. Saarbruecken, Germany, June 5-9, 2007, Abstract P96.
Activated factor XII type A is an independent predictor of all-cause mortality in patients admitted with chest pain.
Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference Chicago, Illinois, April 19-21, 2007. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e128, P519. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
Changes in activated factor XII type A from admission to Day 4 predict recurrent troponin T positive cardiac events following ad
Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference Chicago, Illinois, April 19-21, 2007. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e80, P243. Print ISSN: 1079-5642. Online ISSN: 1524-4636.
Omega-3 Index: A risk factor for ventricular fibrillation in the early post-myocardial infarction phase.
47th Annual Conference Cardiovascular disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism, Orlando, Florida. Circulation 2007; 115; e214-e301: e-237, Abstract P69. Print ISSN: 0009-7322. Onli
No effect of omega-3 versus corn oil intervention on Pregnancy-Associated Plasma Protein A (PAPP-A) and CD-40 Ligand following a
Circulation 2006; 113: e301-e381, abstrakt nummer P315.
No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction.
Circulation 2006; 113: e301-e381, abstrakt nummer P325.
No Protection of a High Omega-3 Index Following an Acute Myocardial Infarction.
Atherosclerosis 2006; 7 (3): Suppl. pp 449.
No protection against new cardiac events of a high Omega-3 Index in patients presenting with an acute coronary syndrome.
Circulation 2006:114(18) (Suppl II): abstr 4176.
Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.
AACC Annual Meeting, 2006, Chicago, Abstract nr. D52.
Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days
Pathophysiol Haemos Thromb2006; 35:199-248
] Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain
Eur Heart J 2006, 27(Abstract Suppl), 878
B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest
Eur Heart J 2006, 27(Abstract Suppl), 570